![Andrew Coats](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Justin Stewart Coats is the founder of Akamis Bio Ltd., founded in 2006, and Actimed Therapeutics Ltd., founded in 2017, where the title held is Non-Executive Director.
Dr. Coats currently holds the position of Chairman at MateraCor, Inc. Former jobs include Director at LoneStar Heart, Inc. and BioVentrix, Inc., Associate Medical Director at Royal Brompton Hospital NHS Trust National Heart & Lung Institute, Deputy Vice Chancellor at The University of Sydney, and Professor at The National Heart & Lung Institute.
Education includes a doctorate from Imperial College London, a doctorate from Oxford Colleges, and an MBA from London Business School.
| Unternehmen | Position | Beginn |
|---|---|---|
Actimed Therapeutics Ltd.
 Actimed Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in treatment of cachexia with a vision to transform care for an under-served and vulnerable patient population | Gründer | 01.01.2017 |
MateraCor, Inc.
 MateraCor, Inc. Medical SpecialtiesHealth Technology Develops cardiac hydrogel implants and endo-cardial delivery systems | Vorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
BioVentrix, Inc.
 BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Direktor/Vorstandsmitglied | - |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Gründer | - |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Royal Brompton Hospital NHS Trust National Heart & Lung Inst
 Royal Brompton Hospital NHS Trust National Heart & Lung Inst Hospital/Nursing ManagementHealth Services Provides treatment for asthma and chronic lung diseases | Corporate Officer/Principal | - |
The National Heart & Lung Institute
 The National Heart & Lung Institute Miscellaneous Commercial ServicesCommercial Services Engages in research, development and education in cardiovascular and respiratory science | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 11 |
|---|---|
BioVentrix, Inc.
BioVentrix, Inc. Medical SpecialtiesHealth Technology Develops and medical devices for the treatment of heart failures | Health Technology |
LoneStar Heart, Inc.
 LoneStar Heart, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cardiac restorative therapies for patients with heart failure | Commercial Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Colleges
 Oxford Colleges Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Brompton Hospital NHS Trust National Heart & Lung Inst
Royal Brompton Hospital NHS Trust National Heart & Lung Inst Hospital/Nursing ManagementHealth Services Provides treatment for asthma and chronic lung diseases | Health Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Heart & Lung Institute
The National Heart & Lung Institute Miscellaneous Commercial ServicesCommercial Services Engages in research, development and education in cardiovascular and respiratory science | Commercial Services |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
Actimed Therapeutics Ltd.
Actimed Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in treatment of cachexia with a vision to transform care for an under-served and vulnerable patient population | Commercial Services |
MateraCor, Inc.
MateraCor, Inc. Medical SpecialtiesHealth Technology Develops cardiac hydrogel implants and endo-cardial delivery systems | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
